Incorporating founder virus information in vaccine field trials

DOI10.1111/BIOM.12277zbMath1390.62255OpenAlexW2133906271WikidataQ36509005 ScholiaQ36509005MaRDI QIDQ3459936

Dean A. Follmann, Chiung-Yu Huang

Publication date: 11 January 2016

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc4729213

zbMATH Keywords

empirical processCox regressioninfectious diseasecompeting risksmarked processburden of illness

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) General nonlinear regression (62J02)

Cites Work

• Unnamed Item
• Proportional hazards models with continuous marks
• Design and analysis of vaccine studies
• Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials
• The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
• The Analysis of Failure Times in the Presence of Competing Risks
• Asymptotic Statistics
• On Profile Likelihood
• Augmented Designs to Assess Immune Response in Vaccine Trials
• Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization

This page was built for publication: Incorporating founder virus information in vaccine field trials